Partner Content Partner Content Disruptive Technologies in Pharma 2020 - the "Healthcare Dis... AI in Pharma
Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
Views & Analysis How artificial intelligence is empowering healthcare It is hard to think of any area of our lives that might not one day be affected by artificial intelligence, and an exponential rise in recent years has already seen it become increasingly e
Partner Content Partner Content 3rd Annual AI-ML Drug Discovery & Development Summit Discover Case Studies of Machine Learning in Action
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
